GKB Ophthalmics Ltd (GKB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 360373, "name": "GKB Ophthalmics", "stock_name": "GKB Ophthalmics", "full_name": "GKB Ophthalmics Ltd", "name_url": "stocks-analysis/gkb-ophthalmics", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "64.00", "chg": -1.54, "chgp": "-2.35%", "dir": -1, "prev_price": "65.54", "mcapval": "33.00 Cr", "mcap": "Micro Cap", "scripcode": 533212, "symbol": "GKB", "ind_name": "Healthcare Services", "ind_code": 31, "sector_id": 35, "indexname": "India SENSEX", "isin": "INE265D01015", "curr_date": "Aug 31, 03:59 PM", "curr_time": "16:03 PM", "last_traded_at": "Aug 31, 03:59 PM IST", "bse_nse_vol": "1.91 k", "exc_status": "Active", "traded_date": "Aug 31, 2026", "traded_date_str": "2026 08 31", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gkb-ophthalmics-360373-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "GKB Ophthalmics Ltd Locks at Upper Circuit With 8.6% Gain — Buyers Queue, Sellers Absent", "link": "https://www.marketsmojo.com/news/stocks-in-action/gkb-ophthalmics-ltd-hits-upper-circuit-amid-strong-buying-pressure-4176240", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GKBOphthalmicsL_stocks_hitting_upper_circuit_4176240.png", "date": "2026-08-31 12:00:08", "description": "At Rs 68.75, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. GKB Ophthalmics Ltd locked at its upper circuit of 10% on 31 Aug 2026, with buyers queuing and no sellers willing to part with shares." }, { "title": "GKB Ophthalmics Gains 11.32%: Key Financial and Technical Shifts Drive Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/gkb-ophthalmics-gains-1132-key-financial-and-technical-shifts-drive-momentum-4156069", "imagepath": "", "date": "2026-08-15 17:14:44", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>10 Aug:</strong> MarketsMOJO upgrades GKB Ophthalmics to Hold on improving technicals and financials</p>\n <p><strong>13 Aug:</strong> Company reports mixed quarterly results with declining sales but improved profitability</p>\n <p><strong>14 Aug:</strong> Stock closes at ₹65.00, marking an 11.32% weekly gain</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.58.39</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.65.00</div><div class=\"stat-change po..." }, { "title": "GKB Ophthalmics Ltd Reports Mixed Quarterly Results Amid Shifting Financial Trends", "link": "https://www.marketsmojo.com/news/stocks-in-action/gkb-ophthalmics-ltd-reports-mixed-quarterly-results-amid-shifting-financial-trends-4152052", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GKBOphthalmicsL_fintrenddot_4152052.png", "date": "2026-08-13 12:00:13", "description": "GKB Ophthalmics Ltd has demonstrated a cautiously optimistic financial performance in the quarter ended June 2026, with key profitability metrics improving despite a contraction in quarterly net sales. The company’s recent upgrade to a 'Hold' rating reflects a shift from previous concerns, underpinned by stronger returns on capital and higher profit after tax over the last six months." }, { "title": "GKB Ophthalmics Ltd Upgraded to Hold as Technicals and Financials Show Improvement", "link": "https://www.marketsmojo.com/news/stock-recommendation/gkb-ophthalmics-ltd-upgraded-to-hold-as-technicals-and-financials-show-improvement-4146700", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GKBOphthalmicsL_mojoScore_4146700.png", "date": "2026-08-11 08:31:09", "description": "GKB Ophthalmics Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and financial results. The upgrade, effective from 10 August 2026, is driven by a combination of enhanced technical trends, robust quarterly earnings, attractive valuation metrics, and a cautiously optimistic financial trajectory despite some lingering fundamental weaknesses." }, { "title": "GKB Ophthalmics Downgraded to Sell Amid Mixed Financials and Technical Weakness", "link": "https://www.marketsmojo.com/news/stock-recommendation/gkb-ophthalmics-downgraded-to-sell-amid-mixed-financials-and-technical-weakness-4091706", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GKBOphthalmicsL_mojoScore_4091706.png", "date": "2026-07-07 08:34:40", "description": "GKB Ophthalmics Ltd has seen its investment rating downgraded from Hold to Sell as of 6 July 2026, reflecting a complex interplay of financial performance, valuation metrics, and technical indicators. Despite recent positive quarterly results, the company’s long-term fundamentals and technical trends have deteriorated, prompting a reassessment of its outlook within the healthcare services sector." }, { "title": "GKB Ophthalmics Ltd Upgraded to Hold on Improved Technicals and Financial Performance", "link": "https://www.marketsmojo.com/news/stock-recommendation/gkb-ophthalmics-ltd-upgraded-to-hold-on-improved-technicals-and-financial-performance-4080989", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GKBOphthalmicsL_mojoScore_4080989.png", "date": "2026-07-01 08:12:36", "description": "GKB Ophthalmics Ltd has seen its investment rating upgraded from Sell to Hold as of 30 June 2026, reflecting a notable improvement in its technical indicators and financial results. The company’s recent quarterly performance, valuation metrics, and evolving market trends have collectively influenced this reassessment, signalling cautious optimism among investors despite lingering long-term challenges." }, { "title": "GKB Ophthalmics Downgraded to Sell Amid Mixed Financial and Technical Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/gkb-ophthalmics-downgraded-to-sell-amid-mixed-financial-and-technical-signals-4068372", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GKBOphthalmicsL_mojoScore_4068372.png", "date": "2026-06-23 08:28:32", "description": "GKB Ophthalmics Ltd has seen its investment rating downgraded from Hold to Sell as of 22 June 2026, reflecting a complex interplay of deteriorating technical indicators, valuation appeal, and mixed financial trends. Despite recent positive quarterly earnings, the company’s long-term fundamentals and technical outlook have weakened, prompting a reassessment of its investment potential within the healthcare services sector." }, { "title": "GKB Ophthalmics Ltd Upgraded to Hold on Improved Technicals and Financial Performance", "link": "https://www.marketsmojo.com/news/stock-recommendation/gkb-ophthalmics-ltd-upgraded-to-hold-on-improved-technicals-and-financial-performance-4055373", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GKBOphthalmicsL_mojoScore_4055373.png", "date": "2026-06-16 08:29:16", "description": "GKB Ophthalmics Ltd has seen its investment rating upgraded from Sell to Hold as of 15 Jun 2026, reflecting a notable improvement in its technical indicators and financial results. The company’s recent quarterly performance, combined with a shift in market sentiment, has prompted analysts to revise their outlook, signalling cautious optimism for investors in this micro-cap healthcare services stock." }, { "title": "GKB Ophthalmics Declines 2.71% Despite Valuation Upgrade: 4 Key Factors This Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/gkb-ophthalmics-declines-271-despite-valuation-upgrade-4-key-factors-this-week-4052974", "imagepath": "", "date": "2026-06-14 12:01:45", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>1 June:</strong> Upgrade to Hold rating by MarketsMOJO on improved valuation and financial metrics</p>\n <p><strong>1 June:</strong> Valuation parameters shift from risky to very attractive, signalling renewed price appeal</p>\n <p><strong>3 June:</strong> Sharp rebound with a 4.94% gain amid mixed market conditions</p>\n <p><strong>5 June:</strong> Week closes lower at Rs.62.00, down 4.38% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.63.73</div></div>\n <div class=\"sta..." } ], "total": 88, "sid": "360373", "stock_news_url": "https://www.marketsmojo.com/news/gkb-ophthalmics-360373" }, "announcements": [ { "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report", "datetime": "26-Aug-2026", "details": "The 44th Annual General Meeting of the Company was held on August 25 2026 at 11:00 A.M. at the registered office of the Company at 16-A Tivim Industrial Estate Mapusa Goa-403526.", "source": "BSE" }, { "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM", "datetime": "25-Aug-2026", "details": "The 44th Annual General Meeting of the Company was held today i.e Tuesday August 25th 2026 at 11.00 A. M. at the Registered Office of the Company at 16- A Tivim Industrial Estate Mapusa- Goa 403526.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "14-Aug-2026", "details": "Please find attached copies of newspaper cuttings of the extract of Statement of unaudited Standalone and Consolidated Financial Results for the quarter ended June 30 2026 published in Business standard (English Edition) and on Pudhari ( Marathi) dated August 14 2026.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "GKB Ophthalmics Ltd has declared <strong>12%</strong> dividend, ex-date: 21 Sep 10", "dt": "2010-09-21", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

10 Aug: MarketsMOJO upgrades GKB Ophthalmics to Hold on improving technicals and financials

13 Aug: Company reports mixed quarterly results with declining sales but improved profitability

14 Aug: Stock closes at ₹65.00, marking an 11.32% weekly gain

Read full news article

GKB Ophthalmics Ltd Reports Mixed Quarterly Results Amid Shifting Financial Trends

2026-08-13 12:00:13

GKB Ophthalmics Ltd has demonstrated a cautiously optimistic financial performance in the quarter ended June 2026, with key profitability metrics improving despite a contraction in quarterly net sales. The company’s recent upgrade to a 'Hold' rating reflects a shift from previous concerns, underpinned by stronger returns on capital and higher profit after tax over the last six months.

Read full news article

GKB Ophthalmics Ltd Upgraded to Hold as Technicals and Financials Show Improvement

2026-08-11 08:31:09

GKB Ophthalmics Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and financial results. The upgrade, effective from 10 August 2026, is driven by a combination of enhanced technical trends, robust quarterly earnings, attractive valuation metrics, and a cautiously optimistic financial trajectory despite some lingering fundamental weaknesses.

Read full news article

GKB Ophthalmics Downgraded to Sell Amid Mixed Financials and Technical Weakness

2026-07-07 08:34:40

GKB Ophthalmics Ltd has seen its investment rating downgraded from Hold to Sell as of 6 July 2026, reflecting a complex interplay of financial performance, valuation metrics, and technical indicators. Despite recent positive quarterly results, the company’s long-term fundamentals and technical trends have deteriorated, prompting a reassessment of its outlook within the healthcare services sector.

Read full news article

GKB Ophthalmics Ltd Upgraded to Hold on Improved Technicals and Financial Performance

2026-07-01 08:12:36

GKB Ophthalmics Ltd has seen its investment rating upgraded from Sell to Hold as of 30 June 2026, reflecting a notable improvement in its technical indicators and financial results. The company’s recent quarterly performance, valuation metrics, and evolving market trends have collectively influenced this reassessment, signalling cautious optimism among investors despite lingering long-term challenges.

Read full news article

GKB Ophthalmics Downgraded to Sell Amid Mixed Financial and Technical Signals

2026-06-23 08:28:32

GKB Ophthalmics Ltd has seen its investment rating downgraded from Hold to Sell as of 22 June 2026, reflecting a complex interplay of deteriorating technical indicators, valuation appeal, and mixed financial trends. Despite recent positive quarterly earnings, the company’s long-term fundamentals and technical outlook have weakened, prompting a reassessment of its investment potential within the healthcare services sector.

Read full news article

GKB Ophthalmics Ltd Upgraded to Hold on Improved Technicals and Financial Performance

2026-06-16 08:29:16

GKB Ophthalmics Ltd has seen its investment rating upgraded from Sell to Hold as of 15 Jun 2026, reflecting a notable improvement in its technical indicators and financial results. The company’s recent quarterly performance, combined with a shift in market sentiment, has prompted analysts to revise their outlook, signalling cautious optimism for investors in this micro-cap healthcare services stock.